Fund Overview of Tata India Pharma & Healthcare Fund Direct-IDCW
-
₹1,511.5 CrAUM
-
₹37.44NAV
-
1.10%Expense Ratio
-
EquityFund Category
Minimum amount you can invest: ₹500
Maximum amount you can invest: ₹1,00,000
We have used a return rate of 15% for our calculations.
Tata India Pharma & Healthcare Fund Direct-IDCW Return Comparison
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | -3.21% | NA | 6.12% |
| 6 Months | 7.44% | NA | 12.92% |
| 1 Year | 6.72% | 6.72% | 6.04% |
| 2 Years | 9.74% | 4.76% | 24.93% |
| 3 Years | 71.06% | 19.60% | 25.71% |
| 5 Years | 102.86% | 15.20% | 19.91% |
| 7 Years | 298.27% | 21.83% | NA |
| 10 Years | 326.51% | 15.61% | 12.78% |
Dividends are declared by the fund house based on the income generated from the underlying assets. While many mutual funds distribute dividends annually, the payout frequency ultimately depends on the fund house’s decision
Asset Allocation of Tata India Pharma & Healthcare Fund Direct-IDCW
equities
99.49%other assets or cash equivalents
0.51%Tata India Pharma & Healthcare Fund Direct-IDCW is one Equity mutual fund offered by Tata Mutual Fund. Launched on 28 Dec 2015, the fund aims Long Term Capital Appreciation. Investment in equity/equity related instruments of the companies in the Pharma & Healthcare sector in India. It manages assets worth ₹1,511.5 crore as on Wed Sep 30, 2026. The expense ratio stands at 1.1%. Fund Manager Manager EducationAbout Tata India Pharma & Healthcare Fund Direct-IDCW
The portfolio allocation consists of 99.49% in equities, 0.51% in other assets or cash equivalents.Managed by Rajat Srivastava, it has delivered a return of 6.72% in the last year, a total return since inception of 13.27%.
The latest dividend was declared on 08 May 2026 at 12.00% of face value.
Based on individual goals investors may evaluate which sip is best during the overall investment planning.
Key Metrics of Tata India Pharma & Healthcare Fund Direct-IDCW
-
Standard Deviation16.55%
-
Mean19.20%
-
Sharpe Ratio0.82%
-
Alpha-3.18%
-
Beta1.01%
-
Sortino Ratio1.28%
Tata India Pharma & Healthcare Fund Direct-IDCW Fund Details
|
|
Compare Tata India Pharma & Healthcare Fund Direct-IDCW with other mutual funds in the same category
Tata India Pharma & Healthcare Fund Direct-IDCW
SBI Healthcare Opportunities Fund Direct Plan-Growth
SBI Healthcare Opportunities Fund Direct Plan-IDCW
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| SBI Healthcare Opportunities Fund Direct Plan-Growth |
₹5,870 | 4.94% | 1.38% | 20.99% | 25.46% | 19.69% |
| SBI Healthcare Opportunities Fund Direct Plan-IDCW |
₹5,870 | 4.94% | 1.38% | 20.99% | 25.46% | 19.69% |
| SBI Healthcare Opportunities Fund-Growth |
₹5,870 | 4.85% | 1.13% | 19.79% | 24.17% | 18.45% |
| SBI Healthcare Opportunities Fund-IDCW |
₹5,870 | 4.85% | 1.13% | 19.79% | 24.17% | 18.45% |
| ICICI Prudential Healthcare Fund Direct-Growth |
₹6,861 | 3.40% | -1.15% | 7.63% | 22.70% | 17.19% |
| ICICI Prudential Healthcare Fund Direct-IDCW |
₹6,861 | 3.40% | -1.15% | 7.63% | 22.70% | 17.19% |
| Mirae Asset Healthcare Fund Direct-Growth |
₹3,494 | 5.10% | 3.09% | 22.03% | 24.58% | 17.02% |
| Mirae Asset Healthcare Fund Direct-IDCW |
₹3,494 | 5.10% | 3.09% | 22.03% | 24.58% | 17.02% |
| UTI Healthcare Fund Direct-Growth |
₹1,430 | 3.56% | 0.97% | 17.27% | 24.39% | 16.87% |
| UTI Healthcare Fund Direct-IDCW |
₹1,430 | 3.56% | 0.97% | 17.27% | 24.39% | 16.87% |
More funds from Tata Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Tata India Pharma & Healthcare Fund Regular-Growth
|
₹1,511 | 2.60% | -3.55% | 6.69% | 5.22% | 17.86% |
|
Tata India Pharma & Healthcare Fund Direct-Growth
|
₹1,511 | 2.72% | -3.21% | 7.44% | 6.72% | 19.60% |
|
Tata India Pharma & Healthcare Fund Regular-IDCW
|
₹1,511 | 2.60% | -3.55% | 6.69% | 5.22% | 17.86% |
|
Tata Nifty Midsmall Healthcare Index Fund Regular-Growth
|
₹221 | 5.01% | 1.58% | 14.51% | 18.01% | - |
|
Tata Nifty Midsmall Healthcare Index Fund Direct-Growth
|
₹221 | 5.07% | 1.74% | 14.86% | 18.73% | - |
|
Tata Nifty Midsmall Healthcare Index Fund Regular-IDCW
|
₹221 | 5.01% | 1.58% | 14.51% | 18.01% | - |
|
Tata Nifty Midsmall Healthcare Index Fund Direct-IDCW
|
₹221 | 5.07% | 1.74% | 14.86% | 18.73% | - |
Tata India Pharma & Healthcare Fund Direct-IDCW Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| Nippon India Pharma Fund-Growth |
₹9,166 | ₹568.91 | 17.90% | 13.57% | 15.06% |
| Nippon India Pharma Fund Direct-Growth |
₹9,166 | ₹640.95 | 18.96% | 14.59% | 16.08% |
| Nippon India Pharma Fund-IDCW |
₹9,166 | ₹122.85 | 17.90% | 13.57% | 15.06% |
| Nippon India Pharma Fund Direct-IDCW |
₹9,166 | ₹175.42 | 18.96% | 14.59% | 16.08% |
| ICICI Prudential Healthcare Fund Direct-Growth |
₹6,861 | ₹47.09 | 22.70% | 17.19% | - |
| ICICI Prudential Healthcare Fund-Growth |
₹6,861 | ₹43.25 | 21.69% | 16.18% | - |
| ICICI Prudential Healthcare Fund Direct-IDCW |
₹6,861 | ₹26.43 | 22.70% | 17.19% | - |
| ICICI Prudential Healthcare Fund-IDCW |
₹6,861 | ₹23.23 | 21.69% | 16.18% | - |
| SBI Healthcare Opportunities Fund-Growth |
₹5,870 | ₹522.56 | 24.17% | 18.45% | 14.48% |
| SBI Healthcare Opportunities Fund Direct Plan-Growth |
₹5,870 | ₹606.22 | 25.46% | 19.69% | 15.73% |
Tata India Pharma & Healthcare Fund Direct-IDCW Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.92% | ₹146.17 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.43% | ₹132.02 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.43% | ₹132.02 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.43% | ₹132.02 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.43% | ₹132.02 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.43% | ₹132.02 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.43% | ₹132.02 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.87% | ₹130.76 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.38% | ₹130.11 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.03% | ₹130.01 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.03% | ₹130.01 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.59% | ₹127.09 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.59% | ₹127.09 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.34% | ₹127.07 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.66% | ₹125.61 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.51% | ₹123.89 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.51% | ₹123.89 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.51% | ₹123.89 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.51% | ₹123.89 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 7.99% | ₹120.84 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| SBI Healthcare Opportunities Fund Direct Plan-Growth |
₹606.22 | 25.46% | 19.69% | - |
| SBI Healthcare Opportunities Fund Direct Plan-IDCW |
₹421.18 | 25.46% | 19.69% | - |
| SBI Healthcare Opportunities Fund-Growth |
₹522.56 | 24.17% | 18.45% | - |
| SBI Healthcare Opportunities Fund-IDCW |
₹329.19 | 24.17% | 18.45% | - |
| ICICI Prudential Healthcare Fund Direct-Growth |
₹47.09 | 22.70% | 17.19% | - |
| ICICI Prudential Healthcare Fund Direct-IDCW |
₹26.43 | 22.70% | 17.19% | - |
| Mirae Asset Healthcare Fund Direct-Growth |
₹53.16 | 24.58% | 17.02% | - |
| Mirae Asset Healthcare Fund Direct-IDCW |
₹32.02 | 24.58% | 17.02% | - |
| UTI Healthcare Fund Direct-Growth |
₹388.33 | 24.39% | 16.87% | - |
| UTI Healthcare Fund Direct-IDCW |
₹300.15 | 24.39% | 16.87% | - |
Frequently Asked Questions
Tata India Pharma & Healthcare Fund Direct-IDCW
What is the current AUM of Tata India Pharma & Healthcare Fund Direct-IDCW?
As of Wed Sep 30, 2026, Tata India Pharma & Healthcare Fund Direct-IDCW manages assets worth ₹1,511.5 crore
How has Tata India Pharma & Healthcare Fund Direct-IDCW performed recently?
- 3 Months: -3.21%
- 6 Months: 7.44%
What is the long-term performance of Tata India Pharma & Healthcare Fund Direct-IDCW?
- 3 Years CAGR: 19.60%
- 5 Years CAGR: 15.20%
- Since Inception: 13.27%
What is the portfolio composition of Tata India Pharma & Healthcare Fund Direct-IDCW?
Equity: 99.49%, Others: 0.51%.
Who manages Tata India Pharma & Healthcare Fund Direct-IDCW?
Tata India Pharma & Healthcare Fund Direct-IDCW is managed by Rajat Srivastava from Tata Mutual Fund.
When was the last dividend declared by Tata India Pharma & Healthcare Fund Direct-IDCW?
Latest dividend was declared on 08 May 2026 at 12.00% of face value.
What is the market-cap allocation of Tata India Pharma & Healthcare Fund Direct-IDCW?
Large Cap: 26.08%, Mid Cap: 34.56%, Small Cap: 39.36%.
Which are the top companies Tata India Pharma & Healthcare Fund Direct-IDCW has invested in?
- Sun Pharmaceutical Industries Ltd – 10.92% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 8.43% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 8.43% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 8.43% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 8.43% of the fund's portfolio
Which are the major sectors Tata India Pharma & Healthcare Fund Direct-IDCW focuses on?
- Healthcare – 182.02% of the fund's portfolio




